Cultural Update: The Abortion Pill Harms Women; Dads Are Spending More Time With Their Kids
Think Biblically: Conversations on Faith & Culture
Talbot School of Theology at Biola University / Sean McDowell & Scott Rae
4.8 • 1.3K Ratings
🗓️ 2 May 2025
⏱️ 59 minutes
🔗️ Recording | iTunes | RSS
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | The largest study on the abortion pill ever finds that it significantly harms women. |
| 0:08.0 | Fathers are spending more time with their kids post-COVID. |
| 0:11.4 | A possible alarming trend in the job market is it related to AI competing with college grads. |
| 0:19.0 | And after a century of study, happiness experts come to some |
| 0:23.0 | conclusions that should not surprise bivocally minded Christians. These are the stories we will discuss, |
| 0:29.2 | and we will also address some of your questions. I'm your host, Sean McDowell. |
| 0:33.2 | I'm your co-host, Scott Ray. This is the Think Biblical Weekly Cultural Update, brought |
| 0:37.8 | to you by Talb School Theology, Biola University. Scott, this first story dropped earlier |
| 0:43.8 | in the week, so some other podcasts have talked about it, but my instant thought was two things. |
| 0:49.7 | We've got to discuss this, and given that this is in your lane, I've been really interested all week |
| 0:54.9 | in your take on this. Here's some of the backdrop for folks. This is the largest study. |
| 1:01.4 | It came out of the Ethics and Public Policy Center. Largest known study of the abortion |
| 1:08.3 | pill based on analysis from 2017 to 2023 that includes over 865,000 |
| 1:16.3 | prescribed mifoprestone patients who took mifoprestone. What's interesting is according to |
| 1:23.1 | Danco laboratories who markets this, it's a safe and effective abortion pill. |
| 1:30.2 | But this research shows quite different results. |
| 1:34.7 | The manufacturer and the FDA rely on the results of 10 clinical trials with a total of 30,000 |
| 1:40.8 | participants, and they say less than 0.5% of whom experienced serious adverse reactions. |
| 1:49.8 | In contrast, when they studied real-world insurance claims, where individuals again prescribed |
| 1:56.5 | Mithoprestome, and broadly representative, they said these are not just selective women, |
| 2:02.9 | but all representatives. They said, we get very different results in the USA Today. They found |
| 2:10.2 | adverse event rate of almost 11%. That's 22 times as high as the summary figure reported on the drug label. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Talbot School of Theology at Biola University / Sean McDowell & Scott Rae, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Talbot School of Theology at Biola University / Sean McDowell & Scott Rae and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

